ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Abeona Therapeutics Inc. (ABEO)

Nasdaq · Common stock · Pharmaceutical Preparations

$4.54-0.06 (-1.41%)

As of Oct 21, 2:58 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow ABEO in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on ABEO and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free ABEO chart →

ABEO at a glance

Key statistics

$263.05M

Market capitalization

Previous close
$4.60
Open
$4.66
Day range
$4.53 – $4.66
Volume
415.0K
Average volume (30 sessions)
1.45M
Shares outstanding
57.18M
Earnings per share
$(1.10)
Price / book
2.0
Price / sales
10.3
Beta (1 year, vs SPY)
1.50

Where the price sits in its year

52-week range

15% of the range

Below the 52-week high
-40.7%
Above the 52-week low
+13.4%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$4.95-7.1%
50-day average
$5.56-17.2%
200-day average
$5.52-16.7%
RSI (14)37.3

Between the conventional 30 and 70 bands.

+1.8%

1 week

-18.9%

1 month

-28.3%

3 months

-12.7%

Year to date

-14.5%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with ABEO

Every plan

ABEO on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on ABEO.

See the plans →

Every plan

Screen names like ABEO

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on ABEO

Put ABEO on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on ABEO

See whether there is an open premium alert on ABEO, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

ABEO headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • O'Malley Brendan M.

    −6.7K

    SVP, Chief Legal Officer · Open-market sale

    $34.68K · Sep 29, 2026

  • Seshadri Vishwas

    −19.6K

    Chief Executive Officer, Director · Open-market sale

    $101.09K · Sep 29, 2026

  • Vazzano Joseph Walter

    −9.2K

    Chief Financial Officer · Open-market sale

    $47.39K · Sep 29, 2026

  • Vasanthavada Madhav

    −4.9K

    Chief Commercial Officer · Open-market sale

    $25.27K · Sep 29, 2026

  • Alvino Mark

    −15.0K

    Director · Open-market sale

    $87.97K · Sep 1, 2026

  • Vazzano Joseph Walter

    −1.5K

    Chief Financial Officer · Open-market sale

    $9.65K · Jul 21, 2026

  • Vazzano Joseph Walter

    −24.9K

    Chief Financial Officer · Open-market sale

    $173.26K · Jul 9, 2026

  • Seshadri Vishwas

    −68.0K

    Chief Executive Officer, Director · Open-market sale

    $473.33K · Jul 9, 2026

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
Cleveland, OH
Employees
226
Listed since
Sep 19, 1980
Website
abeonatherapeutics.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.